The importance of adequately addressing patients’ pain levels in parallel with monitoring broader disease activity is further emphasized by the fact that pain has been shown to persist in RA patients who had Disease Activity Score in 28 joints, CRP (DAS28-4[CRP]) < 2.6 for over 1 year [55]. This evidence concerns the gene CRP and rheumatoid arthritis.